Drug Name: | Atenolol (29122-68-7) |
---|---|
PubChem ID: | 2249 |
SMILES: | CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O |
InchiKey: | METKIMKYRPQLGS-UHFFFAOYSA-N |
Therapeutic Category: | Adrenergic Agents, Adrenergic Antagonists, Adrenergic beta-1 Receptor Antagonists, Adrenergic beta-Antagonists, Anti-Arrhythmia Agents, Antihypertensive Agents, Autonomic Agents, Cardiovascular Agents, Neurotransmitter Agents, Peripheral Nervous System Agents, Sympatholytics |
Molecular Weight (dalton) | : | 266.341 |
LogP | : | 0.4521 |
Ring Count | : | 1 |
Hydrogen Bond Acceptor Count | : | 4 |
Hydrogen Bond Donor Count | : | 3 |
Total Polar Surface Area | : | 84.58 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|---|---|---|---|
Dipyridamole (58-32-2) | Asystole | Additive | Not established | Asystole and bradycardia during dipyridamole stress testing in patients receiving beta blockers |
Dipyridamole (58-32-2) | Bradycardia | Additive | Not established | Asystole and bradycardia during dipyridamole stress testing in patients receiving beta blockers |
This panel provides drug-protein interaction and their ADRs along with references
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category